Cas no 27297-39-8 (Sodium lactobionate)
Sodium lactobionate Chemical and Physical Properties
Names and Identifiers
-
- Sodium Lactobionate
- Lactobionic acid sodium
- lactobionic acid sodium salt
- SodiuM LaCLobionate
- BCP22132
- CID 134694960
- 4-O-β-D-Galactopyranosyl-D-gluconic acid sodium salt
- Lactobionic acid sodium salt monohydrate
- D-Gluconic acid, 4-O-b-D-galactopyranosyl-, sodiuM salt(1:1)
- 4-O-BETA-GALACTOPYRANOSYL-D-GLUCONIC ACID MONOSODIUM SALT
- CS-0208898
- AC-8302
- AS-14862
- AKOS015924797
- MFCD06658158
- F71416
- Sodiumlactobionate
- sodium (2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)hexanoate
- 27297-39-8
- Sodium (2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexanoate
- Sodium (2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-
- Sodium lactobionate, 98%
- D-Gluconic acid, 4-O-b-D-galactopyranosyl-, monosodium salt
- Sodium lactobionate
-
- MDL： MFCD06658158
- Inchi： 1S/C12H22O12.Na/c13-1-3(15)10(7(18)8(19)11(21)22)24-12-9(20)6(17)5(16)4(2-14)23-12;/h3-10,12-20H,1-2H2,(H,21,22);/q;+1/p-1/t3-,4-,5+,6+,7-,8-,9-,10-,12+;/m1./s1
- InChI Key： AQKFVNLHZYOMKQ-WWNCWODVSA-M
- SMILES： [Na+].O1[C@H](CO)[C@@H]([C@@H]([C@H]([C@@H]1O[C@H]([C@@H](CO)O)[C@@H]([C@H](C(=O)[O-])O)O)O)O)O
Computed Properties
- Exact Mass: 380.09300
- Monoisotopic Mass: 380.093
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 8
- Hydrogen Bond Acceptor Count: 12
- Heavy Atom Count: 25
- Rotatable Bond Count: 8
- Complexity: 412
- Covalently-Bonded Unit Count: 2
- Defined Atom Stereocenter Count: 9
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 220
Experimental Properties
- Color/Form: No data available
- Melting Point: 160 - 170°C
- Boiling Point: No data available
- Flash Point: No data available
- PSA: 220.43000
- LogP: -7.00360
- Vapor Pressure: No data available
Sodium lactobionate Security Information
- Signal Word：warning
- Hazard Statement： H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
-
Warning Statement：
P264Thoroughly clean after treatment
P280Wear protective gloves/Wear protective clothing/Wear protective goggles/Wear a protective mask
P305If it enters the eyes
P351Rinse carefully with water for a few minutes
P338Remove the contact lens(If any)And easy to operate,Continue flushing
P337If eye irritation persists
P313Obtain medical advice/care - Safety Instruction： H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Storage Condition：Room temperature storage
Sodium lactobionate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | S837262-5g |
Sodium Lactobionate |
27297-39-8 | 99% | 5g |
￥44.00 | 2022-08-31 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | S837262-25g |
Sodium Lactobionate |
27297-39-8 | 99% | 25g |
￥99.00 | 2022-08-31 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | S837262-100g |
Sodium Lactobionate |
27297-39-8 | 99% | 100g |
￥238.00 | 2022-08-31 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | S837262-500g |
Sodium Lactobionate |
27297-39-8 | 99% | 500g |
￥668.00 | 2022-08-31 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | S192464-100g |
Sodium lactobionate |
27297-39-8 | 99% | 100g |
￥148.90 | 2023-09-01 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | S192464-25g |
Sodium lactobionate |
27297-39-8 | 99% | 25g |
￥58.90 | 2023-09-01 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | S192464-500g |
Sodium lactobionate |
27297-39-8 | 99% | 500g |
￥409.90 | 2023-09-01 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | S192464-5g |
Sodium lactobionate |
27297-39-8 | 99% | 5g |
￥29.90 | 2023-09-01 | |
| eNovation Chemicals LLC | D512853-5g |
Sodium lactobionate |
27297-39-8 | 97% | 5g |
$200 | 2023-09-02 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1279568-25g |
Sodium lactobionate |
27297-39-8 | 98% | 25g |
￥58 | 2023-02-16 |
Sodium lactobionate Suppliers
Audited Supplier
Audited Supplier
Sodium lactobionate Related Literature
-
Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
-
Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
-
Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
-
Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
-
Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
Additional information on Sodium lactobionate
Recent Advances in Sodium Lactobionate (27297-39-8) Research: Applications and Innovations in Chemical Biomedicine
Sodium lactobionate (CAS: 27297-39-8), a derivative of lactose, has garnered significant attention in the field of chemical biomedicine due to its versatile applications in drug formulation, organ preservation, and as a biocompatible excipient. Recent studies have explored its role in enhancing the stability and efficacy of therapeutic agents, particularly in parenteral formulations. This research brief synthesizes the latest findings on Sodium lactobionate, highlighting its chemical properties, mechanisms of action, and emerging applications in biomedicine.
One of the most notable advancements in Sodium lactobionate research is its use as a cryoprotectant and organ preservation agent. A 2023 study published in the Journal of Biomedical Materials Research demonstrated that Sodium lactobionate significantly reduces ischemic injury in transplanted organs by stabilizing cell membranes and mitigating oxidative stress. The study utilized a rat liver transplantation model, where organs preserved with Sodium lactobionate exhibited improved viability and reduced post-transplant inflammation compared to traditional preservation solutions. These findings underscore its potential to revolutionize organ transplantation protocols.
In drug delivery systems, Sodium lactobionate has been investigated for its ability to enhance the solubility and bioavailability of poorly water-soluble drugs. A recent Pharmaceutical Research article (2024) reported the development of a novel nanoparticle-based delivery system incorporating Sodium lactobionate as a stabilizer. The system demonstrated a 40% increase in drug loading capacity and sustained release kinetics, making it particularly suitable for anticancer therapies. The researchers attributed these improvements to the compound's amphiphilic nature, which facilitates interactions with both hydrophobic drugs and aqueous environments.
Furthermore, Sodium lactobionate has shown promise in the field of diagnostic imaging. A 2024 study in Contrast Media & Molecular Imaging revealed its utility as a contrast agent enhancer in magnetic resonance imaging (MRI). By chelating gadolinium ions, Sodium lactobionate improved the contrast-to-noise ratio by 25% while reducing the risk of nephrogenic systemic fibrosis, a common side effect of gadolinium-based contrast agents. This innovation could lead to safer and more effective imaging techniques for patients with renal impairment.
Despite these advancements, challenges remain in the large-scale production and standardization of Sodium lactobionate for clinical applications. Recent research published in Biotechnology Progress (2023) has focused on optimizing fermentation processes to increase yield and purity. The study identified specific strain engineering strategies that improved lactobionic acid production by 30%, with subsequent conversion to Sodium lactobionate achieving pharmaceutical-grade purity. These developments are critical for meeting the growing demand in biomedical applications.
Looking ahead, the unique properties of Sodium lactobionate (27297-39-8) position it as a multifunctional agent in chemical biomedicine. Ongoing research is exploring its potential in wound healing, antimicrobial coatings, and as a component of bioinks for 3D bioprinting. As these applications mature, Sodium lactobionate is expected to play an increasingly important role in advancing therapeutic and diagnostic technologies, offering solutions to some of biomedicine's most pressing challenges.
27297-39-8 (Sodium lactobionate) Related Products
- 84366-53-0(L-Mannose,6-deoxy-4-O-D-glucopyranuronosyl-)
- 85684-23-7(beta-D-Glucopyranosiduronic acid, 2-methoxy-1-methylethyl)
- 21675-38-7(D-Gluconic acid, 6-O-a-D-galactopyranosyl-)
- 58189-74-5(1-O-METHYL-BETA-D-GLUCURONIC ACID, SODIUM SALT)
- 96-82-2(Lactobionic acid)
- 6037-45-2(Trigalacturonic Acid (>90%))
- 9049-37-0(Pectic acid, sodium salt)
- 12698-40-7(ALGINIC ACID CALCIUM SODIUM SALT)
- 534-74-7(D-Gluconic acid, 6-O-a-D-glucopyranosyl-)
- 534-41-8(D-Gluconic acid, 4-O-b-D-glucopyranosyl-)
